Loading...

OBIO ORCHESTRA BIOMED HOLDINGS INC US FDA Inspections 8-K Filing

RCHS

B

ORCHESTRA BIOMED HOLDINGS INC

(OBIO)

2023 8-K

Executive Compensation Update

Acquisition Proceeds

Business Update Call

Investor Presentation Update

Termination Agreement

Equity Offerings

Regulatory Compliance

Investigational Device Exem...

Investor Presentation

Executive Compensation Changes

Sales Agreement

Appointment of Director

Annual Meeting Voting Results

Regulation FD Disclosure

Annual Meeting of Stockholders

Agreement Amendment

Regulation FD Disclosure

Registration Statement and ...

FDA Approval for BackBeat C...

Departure of Chief Financia...

Disclosure of Slide Present...

Regulation FD Disclosure

Merger Completed

Meeting Approval

Delisting Notice

General Meeting

External Links:

Orchestra BioMed Holdings, Inc. received FDA approval for its BackBeat Cardiac Neuromodulation Therapy product candidate to treat hypertension in patients indicated for a pacemaker.

AI Assistant

ORCHESTRA BIOMED HOLDINGS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.